{"id":"W2142466432","doi":"10.1016/s1470-2045(12)70560-0","title":"Androgen-deprivation therapy alone or with docetaxel in non-castrate metastatic prostate cancer (GETUG-AFU 15): a randomised, open-label, phase 3 trial","year":2013,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":740,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Institute of Cancer Research; National Cancer Institute; Institut National Du Cancer; Sanofi; Roche; Bayer; AstraZeneca; Unicancer; Novartis; Pfizer; Amgen","keywords":"Medicine; Docetaxel; Androgen deprivation therapy; Prostate cancer; Internal medicine; Oncology; Estramustine; Clinical endpoint; Chemotherapy; Goserelin; Prostate-specific antigen; Urology; Cancer; Randomized controlled trial","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002119288,0.002524046,0.003607764,0.0006872228,0.000526716,0.001288716,0.001140563,0.002173351,0.009512435],"category_scores_gemma":[0.001739526,0.0008748256,0.003305407,0.0005762538,0.002077299,0.001734624,0.0006494942,0.004593729,0.001386284],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001129174,"about_ca_system_score_gemma":0.001332449,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002728285,"about_ca_topic_score_gemma":0.006733971,"domain_scores_codex":[0.9992431,0.0003760021,0.00003508683,0.0001393562,0.00004848044,0.0001579243],"domain_scores_gemma":[0.9991553,0.0002327862,0.0001500839,0.00005954864,0.00003170245,0.0003705852],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9768665,0.004649007,0.0003583039,0.0005284484,0.0008470477,0.00002639747,0.00007064398,0.0004392485,0.0009569621,0.0001403976,0.0009761236,0.01414079],"study_design_scores_gemma":[0.9344261,0.06328947,0.0009390996,0.00002913069,0.0003175977,0.00002963549,0.00002616176,0.0002846013,0.0001342026,0.0001683153,0.0003383452,0.00001726983],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9856737,0.005377793,0.0005834893,0.0008482774,0.0008020346,0.003049458,0.001320308,0.0002345599,0.002110307],"genre_scores_gemma":[0.9866,0.002961982,0.001321319,0.001292122,0.0004411075,0.002445033,0.001254301,0.00004696158,0.003637183],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009512435,"threshold_uncertainty_score":0.0318222,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.14905012062049,"score_gpt":0.4450497540010663,"score_spread":0.2959996333805763,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}